Correction: Female genital schistosomiasis and HIV/AIDS: Reversing the neglect of girls and women.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it.

1. Evaluating the efficacy of the praziquantel dose pole for schistosomiasis treatment: A multi-country systematic review.PLoS neglected tropical diseases · 2025
   Pooled it
2. Diagnostic competence and health worker knowledge of female genital schistosomiasis management in a rural Ghanaian district.PLoS neglected tropical diseases · 2026
   Article
3. Adolescents and young adults excluded from preventive chemotherapy for schistosomiasis control in Northern Tanzania: are they at risk and reservoirs of infection? Prevalence and determinants of transmission in Northern Tanzania.IJID regions · 2022
   Article
4. The parasitology of female genital schistosomiasis.Current research in parasitology & vector-borne diseases · 2022
   Review

Corrections and comments

• Erratum for
  Female genital schistosomiasis and HIV/AIDS: Reversing the neglect of girls and women.2019

Authors and funding

8 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract